Alnylam Pharmaceuticals
ALNY
#446
Rank
$52.54 B
Marketcap
$397.70
Share price
-3.62%
Change (1 day)
56.48%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company